Patents by Inventor Stephen A. Wank

Stephen A. Wank has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040110170
    Abstract: This invention provides CGRP receptors (including both amino acid and nucleic acid sequences). Compositions which include these polypeptides, proteins, nucleic acids, recombinant cells, transgenic animals, and antibodies to the receptors are also provided.
    Type: Application
    Filed: May 16, 2003
    Publication date: June 10, 2004
    Applicant: The Regents of the University of California
    Inventors: Joseph R. Pisegna, Stephen A. Wank
  • Patent number: 6169173
    Abstract: An unconventional approach to purifying CCK receptor protein to sequenceable-grade homogeneity has been discovered. By this approach, CCK receptor protein can be obtained and sequenced routinely from a variety sources, and from the sequence information thus obtained it is possible to prepare oligonucleotides suitable for cloning CCK receptor genes. “CCK receptor” in this context denotes, any from a group of proteins that displays a characteristic CCK binding affinity and that is encoded by a nucleotide sequence which hybridizes a oligonucleotide probe designed in accordance with the criteria elaborated herein.
    Type: Grant
    Filed: March 10, 1993
    Date of Patent: January 2, 2001
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventor: Stephen A. Wank
  • Patent number: 5319073
    Abstract: An unconventional approach to purifying CCK receptor protein to sequenceable-grade homogeneity has been discovered. By this approach, CCK receptor protein can be obtained and sequenced routinely from a variety sources, and from the sequence information thus obtained it is possible to prepare oligonucleotides suitable for cloning CCK receptor genes. "CCK receptor" in this context denotes any from a group of proteins that displays a characteristic CCK binding affinity and that is encoded by a nucleotide sequence which hybridizes a oligonucleotide probe designed in accordance with the criteria elaborated herein.
    Type: Grant
    Filed: September 2, 1992
    Date of Patent: June 7, 1994
    Assignee: The United States of America, as represented by the Department of Health & Human Services
    Inventor: Stephen A. Wank